Navigation Links
The New AIDS Pill

A single pill which combines three drugs is the complete treatment against AIDS. Patients have to take the pill daily to keep the virus that causes the disease// under check.

But still the pill has not come to the market and is expected to hit the markets very soon. Keith Folger of Washington is very happy to hear about the single pill which would keep the virus under check. He started on 36 pills a day about 11 years ago and expects to switch to the new pill when it becomes available. Mr. Folger is the director of community mobilization for the National Association of People with AIDS. The new drug is a combination of drugs such as Sustiva, sold by Bristol-Myers Squibb, and Truvada, sold by Gilead Sciences. Truvada in turn is a combination of two Gilead drugs, Viread and Emtriva.

The FDA would approve the drug and then the drug would be available in the market. The companies said that the drug would cost the same as Sustiva and Truvada which is about $1,200 a month. One other AIDS pill was recently approved by the F.D.A. for use in developing countries. But the new pill constitutes the most widely prescribed regimen in the US and is found to be the most effective pill. But the question posed by the doctors and securities analysts is that how many people taking other drug combinations would switch to the new pill.

Some of them will not because the virus in has already become resistant to one of the drugs in the new pill or because they cannot tolerate the side effects of the pill. Some of the side effects of Sustiva (efavirenz) are unsettlingly vivid dreams and birth defects. Statistics show that nearly 40 million people in the world infected by H.I.V are residing in the developing nations.

In the US there are about 1.1 million AIDS patients. Bristol-Myers and Gilead said that they will make the new pill available at a sharply reduced price for developing nations. An important issue is the development of resistance among the
'"/>




Page: 1 2

Related medicine news :

1. Problems Of a Growing Company
2. Teenagers Take More Risk-Taking Behaviors In The Company Of Same Sex Friends
3. Australian Company Gets $10 million For Developing Skin Cancer Gel
4. Elderly People Prefer The Company Of Pet Dogs
5. Ossur Acquires the U.S. Orthopaedics Company
6. Britain Approves Indian Company For Supplying Medicines
7. Drug Company Admits Knowledge Of Side Effects In Monkeys
8. Ranbaxy Expands By Acquiring A Generic Company In Belgium
9. Indian Training Company To Train Children In Dubai, Sharjah
10. GE Healthcare to Acquire Swedish Medical Company
11. New Company Will Seek Drugs Against Diabetes and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The New AIDS Pill

(Date:12/4/2009)..., , NEW YORK, Dec. 4 Tho... than 90 offices nationwide today, to participate ...dit, tax and advisory firm,s support for literacy ...ice day reflects our firm,s long history of volunt...gathered in the spirit of caring to brighten the h...
(Date:12/4/2009)..., , SCOTTSDALE, Ariz., Dec. 4 /PRNewswire/...elf-managed, non-traded, real estate investment tr...e agreement to acquire a three building medical of...cana, Texas, and Fort Wayne, Indiana for approxima...is subject to the satisfaction of a number of cond...
(Date:12/4/2009)..., , WASHINGTON, Dec. 4 /PRNewswire-USNew...re reform would control health care costs, Leapfro...ead through example -- delivering the best quality...vels of efficiency. Thirty-four urban, eight child...09 Leapfrog Top Hospitals, based on results from T...
(Date:12/4/2009)..., Working with mice, scientists at Johns Hopkins...ave shown that a protein made by a gene called "Tw...ately distinguish stem cells that drive aggressive...r cells. , Building on recent work suggesting th...in breast tumors that drives breast cancer, scient...
(Date:12/4/2009)... Dental tourism is a phen...g for an alternative to the high price of dental w...ir search for lower priced dental care, people hav...oice as a dental tourist destination. , ...eing in business for more than 6 years, Mexican De...
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3
... 2008 Elderly patients who use antipsychotic drug...neumonia compared to non-users. This risk is highe...creases gradually thereafter. These findings are p...and behavioral problems associated with dementia a...
... Weems, Congressman Gene Green,Among High-Level Pa... in,Health Care At U.S. News & World Report Breakf...,issued by U.S. News & World Report:, EVENT TOPIC...are, will examine the "value paradigm",between adv...
...s more than 786,000 workers, CHICAGO, April 15 T...e release of its updated statistical map entitled ...sion in 2006" that details how,many employees, bro...se employees. The data clearly shows how much the,...
...ve Workflow Tools Will Help Public Health Move Be...True Community Health Surveillance ...g Systems (HMS), (http://www.hmsinc.com ), pioneer...ools that empower epidemiologists and others in,pu...
...sults of a phase IV, open label, head-to-head stud...uency subcutaneous Rebif (interferon beta-1a) prov...lar efficacy over 18 to 30 months of continued the... and Opinion journal. , The Prospective and Retro...
...ses too much on treatments and not enough on preve...run for many women, say researchers at Michigan St...ias coverage of the disease found that over a two-...t, while only 18 percent looked at prevention. , ...
Other Medicine News:Health News:Top Policy Experts to Debate Link Between Rising Health Care Costs and Advances in Medical Technology, Wednesday, April 16, 2008, From 8:30 - 10:00 A.M., at DC's National Press Club 2Health News:Academy of General Dentistry Releases Updated Employment Statistical Map 2Health News:Health Monitoring Systems Releases EpiCenter(TM) 2Health News:Health Monitoring Systems Releases EpiCenter(TM) 3Health News:Health Monitoring Systems Releases EpiCenter(TM) 4Health News:Study shows that high-dose, high-frequency interferon produces no additional benefit 2Health News:Study finds media coverage of breast cancer focuses too little on prevention 2
(Date:12/4/2009)...NGTON, Dec. 4 Chemistr...shed by the Pharmaceutical Research and Manufactu...drugs and vaccines in development for HIV/AIDS and...hat the 97 products in development include 23 vacc...human clinical trials or awaiting approval by the ...
(Date:12/4/2009).... 4 PharmAthene, Inc. (N...medical countermeasures against biological and che... presenting results of a study demonstrating the e...thrax model in the New Zealand White (NZW) rabbit....ion at the HHS Public Health Emergency Medical Cou...
(Date:12/4/2009)...STON, Dec. 4 OrthoAccel Technologi...hich is an acceleration device to enhance orthodon...ng Education course published by PennWell Corpora... industries, including medicine and dentistry. Th...c treatment, a summary of treatment biomechanics, ...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4State National Nursing Home Caregivers 3A Medicare Funding Cut to Long Term Care Will Jeopardize Vital Staffing Positions and Compromise Care for New 54470 1State National Nursing Home Caregivers 3A Medicare Funding Cut to Long Term Care Will Jeopardize Vital Staffing Positions and Compromise Care for New 54470 2State National Nursing Home Caregivers 3A Medicare Funding Cut to Long Term Care Will Jeopardize Vital Staffing Positions and Compromise Care for New 54470 3Korea Institute of Toxicology Implementing Xybion 26apos 3Bs Pristima 26amp 3B 238482 3B 13553 1Korea Institute of Toxicology Implementing Xybion 26apos 3Bs Pristima 26amp 3B 238482 3B 13553 2Patheon Announces Date of Third Quarter 2009 Financial Results Release Conference Call and Webcast 54467 1Patheon Announces Date of Third Quarter 2009 Financial Results Release Conference Call and Webcast 54467 2
...E: LLY ) has submitted a supplemental New Drug Ap...tration (FDA) seeking approval for a new,indicatio...ent of chronic,pain, the company announced today. ...ials in chronic osteoarthritis pain of the knee an...previously completed pain studies in,diabetic peri...
...ccessfully placed in three patient...May 29 Three patients with established,cardiac is... vProtect,Luminal Shield, a self-expanding intraco...y that typically occurs when stents are deployed. ...ort for the vessel to ensure that,the target coron...
Other Medicine Technology:Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration 2Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration 3Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield 2
Avitene Flour
CODMAN Steerable Neuroendoscope
D185 MultiPulse Cortical Stimulator
The Wilson Plus Radiolucent Wilson Frame
Medicine Products: